Alpine Global Management, LLC Mannkind Corp Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$1.14 - $2.25 $314,212 - $620,156	-275,625 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.02 - $2.05 $281,137 - $565,031	275,625 New	275,625 $292,000
Q2 2018 Aug 15, 2018	SELL	$1.59 - $2.38 $44,472 - $66,568	-27,970 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$2.28 - $3.8 $115,584 - $192,641	-50,695 Reduced 64.44%	27,970 $64,000
Q4 2017 Feb 14, 2018	BUY	$2.28 - $6.71 $179,356 - $527,842	78,665	78,665 $183,000

243

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.